What’s new

• Board approved audited standalone and consolidated results for Q4 and FY26.
• KPMSS & Associates reappointed as cost auditor for FY27.
• Bhuwania & Agrawal Associates reappointed as internal auditor for FY27.

Why it matters

The filing is purely procedural. The board approves audited numbers that will be detailed later. No strategic decisions or guidance were announced, limiting market impact.

What we’re watching

• The detailed FY26 financial statements when released.
• Any management commentary on FY27 outlook.
• Trading window reopening 48 hours after Q1 FY27 results.

The full read

A routine board meeting. Hexagon Nutrition's board approved audited FY26 financials on June 30. This is a standard regulatory step that introduces no new business or strategy. The company also reappointed KPMSS & Associates as cost auditor and Bhuwania & Agrawal as internal auditor for FY27. The trading window stays open until 48 hours after Q1 FY27 results. Shareholders await the detailed statements and any management commentary for insight.

Primary source: BSE · NSE

What’s new

• Board approved audited standalone and consolidated FY26 results
• Reappointed KPMSS & Associates as cost auditor for FY27
• Reappointed Bhuwania & Agrawal Associates as internal auditor for FY27

Why it matters

This is a procedural filing that confirms previously announced numbers and routine auditor renewals. It offers zero new information about operations, strategy, or outlook. Investors can skip it.

What we’re watching

• Next quarter's performance vs. FY26 trends
• Any management commentary on demand or margins
• No stock-moving catalysts on the immediate horizon

The full read

Hexagon Nutrition's board met on June 30 and approved the audited FY26 results, plus reappointed the cost and internal auditors. The numbers were already public; the appointments are standard. Nothing changed. The stock trades at ₹707 crore market cap with a P/E of 29.0 and low debt. This is a filing to note and move on. The next real update will be the quarterly commentary.

Primary source: BSE · NSE

What’s new

• First audited results since listing: net profit up 42% to ₹38.15 crore.
• Revenue from operations rises to ₹319.12 crore for FY26.
• Board reappoints cost and internal auditors for FY27 (a routine compliance move).

Why it matters

These are Hexagon Nutrition's first annual numbers as a public company, and they show solid profit growth outpacing revenue. The filing is standard (no surprises), but the underlying performance sets a credible earnings baseline, supporting the P/E of 29. Low debt (0.14) and 12.6% ROE add to the quality signal.

What we’re watching

• Whether management offers any revenue or margin guidance in the coming months.
• If the profit momentum sustains into FY27 first quarter.
• Any expansion in institutional holding after the maiden full-year disclosure.

The full read

Hexagon Nutrition's first full-year report as a listed company lands with a clean beat. Net profit rose 42% to ₹38.15 crore on revenue of ₹319.12 crore — profit outpaced revenue. Clean.

The rest is housekeeping: the board reappointed cost and internal auditors, a procedural move. At a market cap of ₹707 crore and a trailing P/E of 29, the stock already prices in decent execution, and low debt of 0.14 times equity together with a 12.6% ROE reinforces the quality narrative that investors have been assigning a premium for. But this is a baseline, not a catalyst. The open question is whether the margin improvement holds, and whether management will start giving forward guidance. For now, the filing confirms what the market already suspected: Hexagon is growing well, but no surprises.

Primary source: BSE · NSE

What’s new

• Consolidated net profit jumped 56% to ₹37.94 crore for the year ended March 2026.
• Revenue climbed to ₹382.63 crore, reflecting strong operational growth.
• Board reappointed cost and internal auditors for FY27, a routine procedural step.

Why it matters

The 56% profit surge shows Hexagon's growth momentum in its first full year as a listed entity. But the filing is standard post-listing compliance with no strategic update or guidance change, limiting its market-moving potential.

What we’re watching

• Whether next quarter sustains the growth trajectory.
• Any management commentary on future demand or margin outlook.
• Share price reaction given the routine nature of the filing.

The full read

Hexagon Nutrition turned in its first audited numbers as a listed company on July 1, 2026. For the year ended March 2026, consolidated net profit surged 56% to ₹37.94 crore. Revenue came in at ₹382.63 crore. The growth is strong. But the filing carries no surprises. The board re-appointed auditors. That is routine. The results are procedural, merely Regulation 33 compliance, and offer no strategic update or guidance shift. At a ₹707 crore market cap and trailing P/E of 29x, the stock already prices in decent momentum. The first full-year audited figures since listing establish a baseline for all future comparisons, but with no management guidance or commentary, the market has little new to react to. It's a clean set of numbers that keep the story on track.

Primary source: BSE · NSE